Motif Bio Plc (NASDAQ:MTFB) has been given a consensus broker rating score of 1.00 (Strong Buy) from the one analysts that cover the company, Zacks Investment Research reports. One investment analyst has rated the stock with a strong buy rating.

Analysts have set a one year consensus price target of $31.50 for the company, according to Zacks. Zacks has also given Motif Bio Plc an industry rank of 109 out of 265 based on the ratings given to related companies.

Separately, HC Wainwright set a $32.00 price target on Motif Bio Plc and gave the company a “buy” rating in a research report on Wednesday, October 11th.

Motif Bio Plc (NASDAQ MTFB) traded down $0.39 on Friday, hitting $8.60. The stock had a trading volume of 800 shares, compared to its average volume of 5,181. Motif Bio Plc has a 1 year low of $5.25 and a 1 year high of $13.75.

TRADEMARK VIOLATION WARNING: This story was reported by Watch List News and is owned by of Watch List News. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this story can be accessed at https://www.watchlistnews.com/zacks-motif-bio-plc-mtfb-given-31-50-average-price-target-by-brokerages/1723995.html.

Get a free copy of the Zacks research report on Motif Bio Plc (MTFB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Motif Bio Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motif Bio Plc and related companies with Analyst Ratings Network's FREE daily email newsletter.